ELITE PHARMACEUTICALS INC /DE/ — Form D
ELITE PHARMACEUTICALS INC /DE/ of NORTHVALE, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2013-04-23. The offering totals $10.4M, of which $205K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-04-23
- Form: D
- Accession: 0001053369-13-000029
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $10.4M
- Amount sold: $205K
- Remaining: $10.2M
- Investors: 1
- Date of first sale: 2013-04-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-195404
Issuer
- Name: ELITE PHARMACEUTICALS INC /DE/
- CIK: 0001053369
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Phone: 2017502646
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Chris Dick | Director | Northvale, NJ |
| Chris Dick | Executive Officer | Northvale, NJ |
| Jerry Treppel | Executive Officer | Northvale, NJ |
| Carter Ward | Executive Officer | Naples, FL |
| Douglas Plassche | Executive Officer | Northvale, NJ |
| Barry Dash | Director | Northvale, NJ |
| Nasrat Hakim | Director | Northvale, NJ |
| Nasrat Hakim | Executive Officer | Northvale, NJ |
| Davis Caskey | Director | Northvale, NJ |
| Jeffrey Whitnell | Director | Northvale, NJ |
| Eugene Pfeifer | Director | Northvale, NJ |
| Jerry Treppel | Director | Northvale, NJ |
| Ashok Nigalaye | Director | Laurelton, NY |
| Ashok Nigalaye | Executive Officer | Laurelton, NY |
| Jeenarine Narine | Director | Laurelton, NY |
| Robert J Levenson | Director | East Rutherford, NJ |
| Melvin Van Woert | Director | Northvale, NJ |
| Mark Gittelman | Executive Officer | Northvale, NJ |
Other filings by this issuer (4)
More